Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Inotiv, Inc.

NOTVNASDAQ
Healthcare
Medical - Diagnostics & Research
$0.34
$-0.04(-9.37%)
U.S. Market opens in 13h 15m

Inotiv, Inc. Fundamental Analysis

Inotiv, Inc. (NOTV) shows moderate financial fundamentals with a PE ratio of -0.17, profit margin of -13.50%, and ROE of -50.77%. The company generates $0.5B in annual revenue with moderate year-over-year growth of 4.54%.

Key Strengths

Cash Position108.86%
PEG Ratio-0.02

Areas of Concern

ROE-50.77%
Operating Margin-6.17%
Current Ratio0.30
We analyze NOTV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -56.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-56.1/100

We analyze NOTV's fundamental strength across five key dimensions:

Efficiency Score

Weak

NOTV struggles to generate sufficient returns from assets.

ROA > 10%
-9.45%

Valuation Score

Excellent

NOTV trades at attractive valuation levels.

PE < 25
-0.17
PEG Ratio < 2
-0.02

Growth Score

Moderate

NOTV shows steady but slowing expansion.

Revenue Growth > 5%
4.54%
EPS Growth > 10%
49.64%

Financial Health Score

Weak

NOTV carries high financial risk with limited liquidity.

Debt/Equity < 1
4.85
Current Ratio > 1
0.30

Profitability Score

Weak

NOTV struggles to sustain strong margins.

ROE > 15%
-5077.35%
Net Margin ≥ 15%
-13.50%
Positive Free Cash Flow
No

Key Financial Metrics

Is NOTV Expensive or Cheap?

P/E Ratio

NOTV trades at -0.17 times earnings. This suggests potential undervaluation.

-0.17

PEG Ratio

When adjusting for growth, NOTV's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Inotiv, Inc. at 0.11 times its book value. This may indicate undervaluation.

0.11

EV/EBITDA

Enterprise value stands at -20.57 times EBITDA. This is generally considered low.

-20.57

How Well Does NOTV Make Money?

Net Profit Margin

For every $100 in sales, Inotiv, Inc. keeps $-13.50 as profit after all expenses.

-13.50%

Operating Margin

Core operations generate -6.17 in profit for every $100 in revenue, before interest and taxes.

-6.17%

ROE

Management delivers $-50.77 in profit for every $100 of shareholder equity.

-50.77%

ROA

Inotiv, Inc. generates $-9.45 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.45%

Following the Money - Real Cash Generation

Operating Cash Flow

Inotiv, Inc. generates limited operating cash flow of $-11.40M, signaling weaker underlying cash strength.

$-11.40M

Free Cash Flow

Inotiv, Inc. generates weak or negative free cash flow of $-28.75M, restricting financial flexibility.

$-28.75M

FCF Per Share

Each share generates $-0.84 in free cash annually.

$-0.84

FCF Yield

NOTV converts -2.45% of its market value into free cash.

-2.45%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.17

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.85

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.51

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

-0.16

vs 25 benchmark

How NOTV Stacks Against Its Sector Peers

MetricNOTV ValueSector AveragePerformance
P/E Ratio-0.1728.25 Better (Cheaper)
ROE-50.77%780.00% Weak
Net Margin-13.50%-20122.00% (disorted) Weak
Debt/Equity4.850.30 Weak (High Leverage)
Current Ratio0.304.66 Weak Liquidity
ROA-9.45%-14687.00% (disorted) Weak

NOTV outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inotiv, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

183.68%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-389.78%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-371.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ